Lauren Fontana

Lauren Fontana

Auto-generated profile, based on publicly available information

Lauren Fontana

Division of Infectious Diseases and International Medicine, Department of Medicine, University of Minnesota , Minneapolis, Minnesota

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 November 2023 in American Journal of Transplantation
Verified
Journal Article
Open access
SHSeyed M. Hosseini‐Moghaddam
Seyed M. Hosseini‐Moghaddam
SKSagar Kothari
Sagar Kothari
AHAtul Humar
Atul Humar
HAHanan Albasata
Hanan Albasata
ZYZachary A Yetmar
Zachary A Yetmar
JFJay Fishman
Jay Fishman
Solid organ transplant recipients (SOTRs) frequently receive adjunctive glucocorticoid therapy (AGT) for Pneumocystis jirovecii pneumonia (PJP). This multicenter cohort of SOTRs with PJP admitted to 20 transplant centers in Canada, the United States, Europe, and Australia, was examined for whether AGT was associated with a lower rate of all-cause intensive care unit (ICU) admission, 90-day death, or a composite outcome (ICU admission or death). Of 172 SOTRs with PJP (median [IQR] age: 60 (51.5-67.0) years; 58 female [33.7%]), the ICU admission and death rates were 43.4%, and 20.8%, respectively. AGT was not associated with a reduced risk of ICU admission (adjusted odds ratio [aOR] [95% CI]: 0.49 [0.21-1.12]), death (aOR [95% CI]: 0.80 [0.30-2.17]), or the composite outcome (aOR [95% CI]: 0.97 [0.71-1.31]) in the propensity score-adjusted analysis. AGT was not significantly associated with at least 1 unit of the respiratory portion of the Sequential Organ Failure Assessment score improvement by day 5 (12/37 [32.4%] vs 39/111 [35.1%]; P = .78). We did not observe significant associations between AGT and ICU admission or death in SOTRs with PJP. Our findings should prompt a reevaluation of routine AGT administration in posttransplant PJP treatment and highlight the need for interventional studies.

6 November 2024 in American Journal of Transplantation
Verified
Journal Article
Open access
RRRasha El Rifai
Rasha El Rifai
KBKaushik Bhunia
Kaushik Bhunia
LFLauren Fontana
Lauren Fontana
KSKurtis J. Swanson
Kurtis J. Swanson
SJScott Jackson
Scott Jackson
Samy Magdy RiadSamy Magdy Riad
Samy Magdy Riad
We analyzed the Scientific Registry of Transplant Recipients (2004-2022) for primary kidney recipients with HIV who had average immunologic risk and were discharged on tacrolimus/mycophenolate mofetil (with or without corticosteroids). Recipients were grouped by induction type: rabbit antithymocyte globulin (r-ATG, n=688) and human interleukin-2 receptor antagonist (IL2Ra, n=467). Kaplan-Meier curves were generated to examine recipient and graft survival by induction type. We used mixed Cox proportional hazard models to determine associations between induction type and outcomes of interest, with adjustments for recipient and donor factors and transplant center as a random effect. Regression with propensity score weighting reduced selection bias from nonrandom induction allocation. The unadjusted 10-year survival rate was 57% for those receiving r-ATG and 64% for those receiving IL2Ra (P<.001). Adjusted risk of death was significantly lower for IL2Ra induction than r-ATG induction with Cox multivariable (hazard ratio, 0.65; 95% CI, 0.47-0.91; P=.01) and inverse probability treatment weighting (hazard ratio, 0.38; 95% CI, 0.29-0.50; P<.01) models. Death-censored kidney graft survival did not differ by induction type in either model. The 1-year rejection rate was 10.1% and 11.6% for r-ATG and IL2Ra recipients, respectively (P=.52). Overall, IL2Ra conferred better long-term survival than r-ATG without increased risk of graft loss.

22 February 2024 in Infection Control & Hospital Epidemiology
Verified
Journal Article
Closed access
PDF file
LFLauren Fontana
Lauren Fontana
MHMorgan Hakki
Morgan Hakki
EOEgon A. Ozer
Egon A. Ozer
ALAmy Laird
Amy Laird
LSLynne Strasfeld
Lynne Strasfeld
Objective: To evaluate the impact of an intervention to limit dispersal from wastewater drain (WWD) sites on meropenem-nonsusceptible Pseudomonas aeruginosa patient and environmental colonization and bloodstream infection (BSI) on a hematopoietic cell transplant (HCT) and hematologic malignancy (HM) unit.Design: This quasi-experimental study included pre/postintervention point-prevalence surveys in July 2019 and June 2020, respectively. The retrospective cohort included HCT/HM patients with P. aeruginosa BSI between 2012 and 2022.Setting: Adult HCT/HM unit at an academic center.Participants: This study included consenting HCT/HM patients on the unit at the time of the point-prevalence surveys. HCT/HM patients with P. aeruginosa BSI between 2012 and 2022.Methods: A quality improvement intervention targeting WWD sites was conceived and implemented on a HCT/HM unit. Pre and postintervention colonization samples were obtained from patients and environmental sites, cultivated on selective media, then characterized by susceptibility testing. Whole-genome sequencing and phylogenetic analysis were performed on select isolates. The impact of the intervention on colonization and BSI was evaluated, as was relatedness among isolates.Results: Although colonization of WWD sites with meropenem-nonsusceptible P. aeruginosa was widespread before and after this intervention, we observed a substantial decline in patient colonization (prevalence rate ratio, 0.35; 95% confidence interval [CI], 0.04–3.12) and BSI (incidence rate ratio, 0.67; 95% CI, 0.31–1.42) after the intervention. Among 3 predominant sequence types (ST-111, ST-446, and ST-308), there was striking genetic conservation within groups and among environmental colonization, patient colonization, and BSI isolates.Conclusions: An intervention targeting WWD sites on a HCT/HM unit had a meaningful impact on meropenem-nonsusceptible P. aeruginosa patient colonization and BSI.

28 July 2023 in Blood Advances
Verified
Journal Article
Open access
PDF file
LFLauren Fontana
Lauren Fontana
LSLynne Strasfeld
Lynne Strasfeld
MHMorgan Hakki
Morgan Hakki
Lauren Fontana, Lynne Strasfeld, Morgan Hakki; Pseudomonas aeruginosa ExoU-associated virulence in hematopoietic cell transplant and hematologic malignancy pati

1 January 2025 in Case Reports in Infectious Diseases
Verified
Journal Article
Open access
AJAndrew Johnston
Andrew Johnston
JYJohnathone Yang
Johnathone Yang
ESElizabeth Schiffman
Elizabeth Schiffman
AGAlison Galdys
Alison Galdys
LFLauren Fontana
Lauren Fontana
Powassan virus (POWV) is a tick‐borne flavivirus transmitted to humans by Ixodes ticks. In this report, we describe an immunocompromised patient who presented with progressive neurologic symptoms and was diagnosed with POWV encephalitis. Additionally, the patient tested positive for Jamestown Canyon virus (JCV), a mosquito‐borne orthobunyavirus , creating a diagnostic dilemma. This case underscores the importance of considering vector‐borne illnesses in immunocompromised individuals who present with neurologic symptoms, particularly during peak arboviral transmission seasons in the United States. It also highlights the complexities of laboratory testing for arboviral infections in these vulnerable patients.

2 March 2026 in Clinical Transplantation
Verified
Journal Article
Open access
SNSashi Niranjan Nair
Sashi Niranjan Nair
PBPaul Bigliardi
Paul Bigliardi
LFLauren Fontana
Lauren Fontana
Antibiotic allergy labels (AALs) are common and often incorrect. They have many potential impacts, including the use of broader‐spectrum antibiotics and suboptimal treatment of infections. The impact of inaccurate allergy labels on post‐transplant outcomes in the solid organ transplant population is not well described. We performed a retrospective review of 2,373 consecutive solid organ transplants occurring between 2011 and 2021, to analyze the impact of AALs, specifically penicillin, on outcomes in the first year after transplantation. Three hundred and twenty‐two patients (13.6%) had a penicillin allergy label, while 572 patients (24%) had at least one antibiotic allergy label. Patients with a penicillin allergy label were more likely to have a positive Clostridioides difficile test ( p = 0.021). Patients with allergy labels also had significantly more utilization of alternative antimicrobial agents ( p < 0.001) and longer inpatient hospital durations ( p = 0.013). This study suggests that AALs may be a risk factor for inferior outcomes after solid organ transplantation and could represent a modifiable target for pre‐transplant optimization.